Effect of Muscle Relaxants on Postoperative Sore Throat in Video Laryngeal Mask Airway(LMA) Use
Effect of Muscle Relaxants on Postoperative Sore Throat in Video Video Laryngeal Mask Airway(LMA) Use: A Randomized Study
- Laryngeal Mask Airway
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- Samsun University
- Enrolment target
- 90
- Started
- 4 May 2026
- Main results due
- 30 December 2026
- Study sites
- 1
- Registry updated
- 24 September 2026
Can you take part?
- Ages 18 years to 70 years.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Cases lasting longer than 1 hour * Participants with body mass index \>30 * Participants with ASA I, II, III Exclusion Criteria: * Participants with a body mass index \< 30 * Pregnant women * Participants with expected difficult airway passage * Cases lasting less than 1 hour
What this study is about
In the sponsor’s own words, from the registry.
Video laryngeal masks (VLMAs) are increasingly used as a minimally invasive alternative in airway management. The use of neuromuscular blocking agents can affect VLMA placement and airway physiology. As a result, there may be differences in postoperative respiratory complications and middle ear pressure.
Study sites(1)
Samsun City Hospital
Samsun, Samsun, Turkey (Türkiye)
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07838051. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me